Advertisement
News
Advertisement

FDA OKs Genzyme's Framingham plant

Tue, 01/24/2012 - 9:48pm
Mass High Tech: The Journal of New England Technology

Less than a week after Genzyme’s Framingham plant landed approval from the European Medicines Agency to manufacture Fabrazyme,  the U.S. Food and Drug Administration has also given the OK to produce the treatment for Fabry disease.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading